In contrast, total GIPELISA and active GIPELISA at 30 min were only 2- and 2.5-fold greater than that of T2DM without DPP-4 inhibitor, respectively (Figures 2A,B). The gene discussed is DPP4; the disease is type 2 diabetes mellitus.